Administration of NF-kappaB decoy inhibits pancreatic activation of NF-kappaB and prevents diabetogenesis by alloxan in mice.

The FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Volumn 15, Issue 9, 2001, Pages 1616-1618

  Quan, N ^a   Ho, E ^a   La, W ^a   Tsai, Y H ^a   Bray, T ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOXAN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN;

ANIMAL; APOPTOSIS; ARTICLE; BIOSYNTHESIS; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; EXPERIMENTAL DIABETES MELLITUS; HYPERGLYCEMIA; METABOLISM; MOUSE; PANCREAS; PANCREAS ISLET;

ALLOXAN; ANIMALS; APOPTOSIS; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; HYPERGLYCEMIA; INSULIN; ISLETS OF LANGERHANS; MICE; NF-KAPPA B; PANCREAS;

MLCS; MLOWN;

EID: 0035404037     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.00-0855fje     Document Type: Article

References (0)